Title: 2015 ACVIM Forum Research Abstract Program Document date: 2015_5_27
ID: 3pnuj5ru_335
Snippet: EFFECT OF GASTROINTESTINAL PARASITES AND VIRAL AGENTS ON FECAL S100A12 CONCENTRATIONS IN PUPPIES. Romy Heilmann 1 , Aurelien Grellet 2 , Niels Gr€ utzner 3 , Jan Suchodolski 1 , J€ org Steiner 1 . 1 Texas A&M University, College Station, Texas, USA, 2 Royal Canin, Aimargues, France, 3 Vetsuisse University Bern, Bern, BE, Switzerland Previous data suggest that S100A12 may be clinically useful as a biomarker of inflammation in both humans and d.....
Document: EFFECT OF GASTROINTESTINAL PARASITES AND VIRAL AGENTS ON FECAL S100A12 CONCENTRATIONS IN PUPPIES. Romy Heilmann 1 , Aurelien Grellet 2 , Niels Gr€ utzner 3 , Jan Suchodolski 1 , J€ org Steiner 1 . 1 Texas A&M University, College Station, Texas, USA, 2 Royal Canin, Aimargues, France, 3 Vetsuisse University Bern, Bern, BE, Switzerland Previous data suggest that S100A12 may be clinically useful as a biomarker of inflammation in both humans and dogs. In dogs with chronic gastrointestinal (GI) disease, fecal S100A12 concentrations were increased and correlated with the severity of clinical disease, endoscopic changes observed in the intestine, and the severity of histologic lesions in the colon. Higher fecal S100A12 concentrations also correlated with a negative outcome in dogs with inflammatory bowel disease. However, the effect of GI pathogens on fecal S100A12 concentrations in dogs has not yet been reported, and this information will be important for any further evaluation of the clinical utility of fecal S100A12 as a marker for GI inflammation. Thus, the aim of this study was to evaluate the effect of the presence and numbers of parasites as well as viral agents that are known to cause GI signs in dogs on fecal S100A12 concentrations in a large cohort of puppies.
Search related documents:
Co phrase search for related documents- chronic gastrointestinal GI disease and inflammatory bowel: 1
- chronic gastrointestinal GI disease and inflammatory bowel disease: 1
- clinical disease and dog human: 1, 2
- clinical disease and GI disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
- clinical disease and GI inflammation: 1, 2, 3, 4
- clinical disease and histologic lesion: 1
- clinical disease and inflammatory bowel: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71
- clinical disease and inflammatory bowel disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70
- clinical disease and large cohort: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33
- clinical disease and negative outcome: 1, 2, 3, 4, 5, 6, 7, 8, 9
- clinical disease and number presence: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13
- clinical disease and study aim: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73
- clinical disease and viral agent: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
- clinical disease severity and GI disease: 1, 2
- clinical disease severity and GI inflammation: 1
- clinical disease severity and inflammatory bowel: 1, 2, 3
- clinical disease severity and inflammatory bowel disease: 1, 2, 3
- clinical disease severity and large cohort: 1, 2, 3, 4
- clinical disease severity and negative outcome: 1
Co phrase search for related documents, hyperlinks ordered by date